Delivery Order SPE2DB20D1050-SPE2DB24FH50K
- Not listed
- The Defense Logistics Agency (DLA) has awarded a $10,445.23 firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of VEMLIDY 25 MG TABLET UU 30S. This delivery order falls under a larger indefinite delivery contract (IDC) with a potential value of $999,999,999.00 awarded by DLA to Amerisourcebergen Drug Corp. The IDC serves as the primary contract vehicle for Amerisourcebergen to deliver pharmaceutical products and medical...
- This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $18,906.73 firm fixed price delivery order is for the supply of VEMLIDY 25 MG TABLET, a pharmaceutical product. The contract has an ultimate completion date of December 31, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
- This is a $21,289.64 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of VEMLIDY 25 MG TABLET medical product. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to provide a comprehensive range of pharmaceutical products and medical supplies to support military healthcare...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of the pharmaceutical product VEMLIDY 25 MG TABLET UU 30S. The contract has a ceiling value of $5,754.35 and a period of performance through April 4, 2024. This delivery order is issued under an indefinite delivery contract (IDC) held by Amerisourcebergen Drug Corp, which has a total potential value of up to...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of VEMLIDY 25 MG TABLET UU 30S. The award, valued at $74,288.73, has a completion date of June 23, 2025. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which provides a comprehensive global pharmaceutical support vehicle through December...
- The U.S. Defense Logistics Agency (DLA) awarded a $2,599.92 Firm Fixed Price Delivery Order contract to Amerisourcebergen Drug Corp's Corporate Office Division for the supply of VEMLIDY 25 MG TABLET. The contract has an ultimate completion date of August 15, 2024. Amerisourcebergen is a major pharmaceutical distributor that holds several Indefinite Delivery Contracts (IDCs) with federal agencies, including a $999,999,999 IDC with DLA Troop Support Medical for delivering a wide range of medical...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to provide 4,564,206,161 units of the pharmaceutical product VEMLIDY 25 MG TABLET in 30-count packages. The $5,193.06 delivery order has a performance period through April 9, 2024. This award is part of a larger indefinite delivery contract (IDC) held by AmerisourceBergen Drug Corp with a potential value of up to $999,999,999.00...
- The Defense Logistics Agency (DLA) awarded a $2,596.53 firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of VEMLIDY 25 MG TABLET UU 30S. This delivery order is part of a larger indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug Corp, valued at up to $999,999,999.00, to provide a comprehensive range of pharmaceutical products and medical supplies to DLA Troop Support Medical facilities...
- This federal contract award from the Defense Logistics Agency (DLA) is a delivery order valued at $8,153.17 with a firm fixed price awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has an ultimate completion date of April 25, 2024 and covers the procurement of VEMLIDY 25 MG TABLET UU 30S, a pharmaceutical product. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution company. The firm fixed price contract is for the supply of VEMLIDY 25 MG TABLET UU 30S, a pharmaceutical product, with a potential value of $2,596.53 and a completion date of February 28, 2024. No set-aside designation was used for this award. Amerisourcebergen Drug Corp holds an Indefinite...
- SPE2DB20D1050Indefinite Delivery Contract
- SPE2DB20D1050-SPE2DB24FH50KDelivery Order
Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, was awarded a $11,114.60 firm fixed price delivery order contract by the Defense Logistics Agency (DLA) to provide VEMLIDY 25 MG TABLET UU 30S, a pharmaceutical product, with a completion date of February 9, 2024. This delivery order is issued under an indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug Corp by DLA, with a potential value of $999,999,999.00 and a performance period through December 31, 2025. The IDC serves as the primary contract vehicle for Amerisourcebergen to deliver pharmaceutical products and medical supplies to DLA Troop Support Medical facilities supporting the Department of Defense. No set-aside designation was used for this contract.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $11.1k | 2/8/24 |